Search research articles
Contact Us
Filters
Showing results (131-140 of 300) with videos related to
Page
of 30
Sort By:
Journal of Biological Regulators and Homeostatic Agents
|
January 1, 1987
IFN-gamma is not the only mediator of suppressed myelopoiesis produced by mononuclear cells from aplastic anemia patients
T Laskay, M Hansson, A Porwit, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1979
Natural NK-cell targets in the mouse thymus: characteristics of the sensitive cell population
M Hansson, K Kärre, R Kiessling, et al.
Environmental Health Perspectives
|
May 1, 1985
Strategies and techniques for sample collection and analysis: experience from the Swedish PCB accidents
C Rappe, S Marklund, L O Kjeller, et al.
European Journal of Haematology
|
May 1, 1995
Increase of monocytes predicts mobilization of peripheral stem and progenitor cells after chemotherapy followed by G-CSF administration
M Hansson, A Svensson, P Engervall, et al.
Parasite Immunology
|
June 1, 1993
Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA
A Sjölander, M Hansson, K Lövgren, et al.
The Science of the Total Environment
|
September 11, 2012
A biokinetic study of 209Po in man
C F Henricsson, Y Ranebo, M Hansson, et al.
Annals of the New York Academy of Sciences
|
February 3, 1999
Binding sites for VIP in the reorganizing mucosa of the irradiated bowel
U Höckerfelt, M Hansson, S Gulbenkian, et al.
The Journal of Infectious Diseases
|
May 1, 1990
Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis
P Pisa, M Gennene, O Söder, et al.
International Journal of Cancer
|
February 20, 1991
Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells
H Naganuma, R Kiessling, M Patarroyo, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 27, 2018
Preclinical evaluation of point-of-care prothrombin time as a biomarker test to guide prothrombin replacement therapy in coagulopathic bleeding
Clare A Balendran, Neil Henderson, Marita Olsson, et al.
Page
of 30
Search research articles
Search
Showing results (131-140 of 300) with videos related to
Sort By:
Page
of 30
Journal of Biological Regulators and Homeostatic Agents
|
January 1, 1987
IFN-gamma is not the only mediator of suppressed myelopoiesis produced by mononuclear cells from aplastic anemia patients
T Laskay, M Hansson, A Porwit, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 1, 1979
Natural NK-cell targets in the mouse thymus: characteristics of the sensitive cell population
M Hansson, K Kärre, R Kiessling, et al.
Environmental Health Perspectives
|
May 1, 1985
Strategies and techniques for sample collection and analysis: experience from the Swedish PCB accidents
C Rappe, S Marklund, L O Kjeller, et al.
European Journal of Haematology
|
May 1, 1995
Increase of monocytes predicts mobilization of peripheral stem and progenitor cells after chemotherapy followed by G-CSF administration
M Hansson, A Svensson, P Engervall, et al.
Parasite Immunology
|
June 1, 1993
Immunogenicity in rabbits and monkeys of influenza ISCOMs conjugated with repeated sequences of the Plasmodium falciparum antigen Pf155/RESA
A Sjölander, M Hansson, K Lövgren, et al.
The Science of the Total Environment
|
September 11, 2012
A biokinetic study of 209Po in man
C F Henricsson, Y Ranebo, M Hansson, et al.
Annals of the New York Academy of Sciences
|
February 3, 1999
Binding sites for VIP in the reorganizing mucosa of the irradiated bowel
U Höckerfelt, M Hansson, S Gulbenkian, et al.
The Journal of Infectious Diseases
|
May 1, 1990
Serum tumor necrosis factor levels and disease dissemination in leprosy and leishmaniasis
P Pisa, M Gennene, O Söder, et al.
International Journal of Cancer
|
February 20, 1991
Increased susceptibility of IFN-gamma-treated neuroblastoma cells to lysis by lymphokine-activated killer cells: participation of ICAM-1 induction on target cells
H Naganuma, R Kiessling, M Patarroyo, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 27, 2018
Preclinical evaluation of point-of-care prothrombin time as a biomarker test to guide prothrombin replacement therapy in coagulopathic bleeding
Clare A Balendran, Neil Henderson, Marita Olsson, et al.
Page
of 30